NCT06498037 2024-07-12
FERRARI
Erasmus Medical Center
Phase 4 Recruiting
Clinical Trials
5 trialsNCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT00916890 2014-01-09
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 4 Suspended
NCT00459277 2012-01-25
Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Archimedes Development Ltd
Phase 3 Completed
NCT00216658 2011-01-24
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
Janssen Pharmaceutical K.K.
Phase 2 Completed